Navigation Links
Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock
Date:11/19/2007

PITTSBURGH, Nov. 19 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced that it completed the sale of 2.14 million shares of 6.50% mandatory convertible preferred stock at $1,000 per share and 53.5 million shares of common stock at $14 per share pursuant to a shelf registration statement previously filed with the Securities and Exchange Commission. The amounts sold include 279,000 shares of preferred stock issued pursuant to the underwriters' exercise of the overallotment option.

The offerings generated net proceeds, after underwriting discounts and expenses, totaling approximately $2.8 billion, which will be used to prepay a portion of the bridge loans that were borrowed to finance in part its acquisition of Merck KGaA's generics business.

The preferred stock will pay, when declared by the Board of Directors, dividends at a rate of 6.50% percent per annum on the liquidation preference of $1,000 per share, payable quarterly in arrears in cash, shares of Mylan common stock or a combination thereof at Mylan's election. The first dividend date will be February 15, 2008.

Each share of preferred stock will automatically convert on November 15, 2010, into between approximately 58.5480 shares and 71.4286 shares of MYL common stock. The conversion rate will be subject to anti-dilution adjustments in certain circumstances. Holders may elect to convert at any time at the minimum conversion rate of 58.5480 shares of common stock for each share of preferred stock. The preferred stock is listed on the New York Stock Exchange under the symbol MYLPrA.

After giving effect to these offerings, MYL will have approximately 302 million shares of common stock outstanding.

The joint book-running managers
'/>"/>

SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... IL (PRWEB) April 01, 2015 ... was joined by other First Spouses from across ... event on March 21, 2015, World Down Syndrome ... for, the rapidly advancing area of Down syndrome ... participating states included Alabama, Alaska, American Samoa, Arizona, ...
(Date:4/1/2015)... 2015 BioPlus Specialty Pharmacy ... has released a new app to keep health care ... chronic hepatitis C virus (HCV) infection. This ‘HCV Treatment ... from the American Association for the Study of Liver ... new direct-acting oral medications to treat HCV have been ...
(Date:4/1/2015)... Vancouver, BC (PRWEB) April 01, 2015 ... recently announced that she is now offering her patients ... and services. Patients can participate in “Beauty Days”, which ... year by Dr Roz Kamani’s Kitsilano Skin Care Clinic. ... will directly tell patients about the latest products and ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 South ... received Provisional Certificate of Authority (PCOA) approval from the ... step in the ongoing development of a retirement community ... individual health, wellness and spiritual development. , America’s aging ... to meet the housing needs of seniors, according to ...
(Date:4/1/2015)... Health Advocate™, Inc., the nation’s leading healthcare ... Corporation, today launched its new Health and Wellness Blog. ... the Health Advocate member website, features timely and reliable ... , “We’re pleased to introduce this new blog and ... Rosen, Executive Vice President, Health Advocate. “The blog is ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... of Obesity , In a study that addressed ... disordered breathing (SDB), Naresh Punjabi, M.D., Ph.D. sought to ... the best tools at his disposal to do so. ... in insulin production and glucose metabolism. It was published ...
... half of family caretakers surveyed in British study , , THURSDAY, ... members looking after people with dementia admit they have behaved ... Actual physical abuse was rare, being reported by only three ... researchers, who published their findings in the Jan. 23 online ...
... SeQual Technologies Inc., a medical equipment manufacturer ... reliability, quality, and revolutionary design and economy, announces ... the U.S. Army,s Research, Development, and Engineering Command ... indicates that the Eclipse(R) Oxygen Concentrator 1000A is ...
... MOBILE, Ala., Jan. 22 An indictment was ... of a pharmacy and four pharmacists, with participating ... of dosages of anabolic steroids - including powerful ... to users throughout the United States, announced U.S. ...
... Nancy Pelosi released the following statement today in ... Wade:"On the 36th anniversary of Roe v. Wade, ... right to make her own reproductive health care ... in a new President who is committed to ...
... of Medicine have discovered how a whole class of ... findings, reported online this week at the Proceedings ... suggest that a subgroup of cancer patients might particularly ... chemotherapeutics doxorubicin (Adriamycin), daunorubicin, epirubicin, idarubicin have ...
Cached Medicine News:Health News:Sleep disordered breathing and obesity: Independent effects, causes 2Health News:Sleep disordered breathing and obesity: Independent effects, causes 3Health News:Sleep disordered breathing and obesity: Independent effects, causes 4Health News:Sleep disordered breathing and obesity: Independent effects, causes 5Health News:Many Alzheimer's Caregivers Admit to Abusive Behavior 2Health News:Many Alzheimer's Caregivers Admit to Abusive Behavior 3Health News:SeQual Technologies is Awarded the U.S. Army Airworthiness Certification 2Health News:Twelve Indicted in Nationwide Anabolic Steroids Probe 2Health News:Twelve Indicted in Nationwide Anabolic Steroids Probe 3Health News:Twelve Indicted in Nationwide Anabolic Steroids Probe 4Health News:Twelve Indicted in Nationwide Anabolic Steroids Probe 5Health News:How chemotherapy drugs block blood vessel growth, slow cancer spread 2Health News:How chemotherapy drugs block blood vessel growth, slow cancer spread 3
(Date:4/1/2015)... , April 1, 2015  The U.S. ... AirStrip® Sense4Baby™ wireless maternal/fetal monitoring ... U.S. by pregnant patients to self-administer non-stress tests ... from the FDA for use accompanied by medical ... the European Commission in 2013 for self-administration, including ...
(Date:4/1/2015)...  Egalet Corporation (Nasdaq: EGLT ) ("Egalet"), ... developing, manufacturing and marketing innovative pain treatments, today ... million aggregate principal amount of its convertible senior ... placement to qualified institutional buyers pursuant to Rule ... amended (the "Act"). Egalet also granted the initial ...
(Date:4/1/2015)... 1, 2015   Advocates for Responsible Care , ... health care professionals, patient advocates and human rights specialists, ... will go live at 9:00 a.m. today. ... Reach is a new campaign to limit rising out-of-pocket ... by Advocates for Responsible Care, in partnership with the ...
Breaking Medicine Technology:AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7'Rx in Reach' Campaign Launches in Georgia 2'Rx in Reach' Campaign Launches in Georgia 3
... 6, 2012  Mylan Inc. (Nasdaq: MYL ) ... of two dermatological products from Valeant Pharmaceuticals. Mylan has ... Phosphate / Benzoyl Peroxide Gel, which is the generic ... manufactured and marketed the generic version of this product ...
... welcomes Michael Podany as Vice President of Sales, West USA ... Mr. Podany will be responsible for developing and managing sales ... Keith (GM, Director of Sales, USA). Mr. ... in creating, managing, and growing a new base of business ...
Cached Medicine Technology:Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 2Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 3Samsung Medison America Appoints Michael Podany as Vice President of Sales, West USA 2
... Intravascular Mikro-Tip Pressure Catheters; Millar manufactures ... pressure sensor catheters for simultaneous high ... suitable for measuring pressure gradients across ... a vascular stenosis. The catheters are ...
... These dual pressure sensor catheters ... injection, slow-speed injection/guide wire, or ... SPC-784A for high-speed injection has ... openings and an open-end pigtail ...
... Sensor Intravascular Mikro-Tip Pressure Catheters; Millar ... dual pressure sensor catheters for simultaneous ... are suitable for measuring pressure gradients ... across a vascular stenosis. The catheters ...
... Percutaneous Thrombectomy Catheter is a multi-lumen, ... effective and easy removal of fresh, ... HYDROLYSER provides an efficient, patient-friendly alternative ... Compatible with your existing contrast ...
Medicine Products: